New drug combo aims to wipe out hepatitis c virus
Disease control
Completed
This study tested whether a combination of two oral drugs, bemnifosbuvir and ruzasvir, could safely and effectively treat chronic hepatitis C virus (HCV) infection. It involved 275 adults with HCV who had never taken this type of antiviral medication before. The main goal was to …
Phase: PHASE2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC